MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
147.27%
Quick Ratio
116.66%
Debt to Asset Ratio
109.68%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating right of use assets
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Long-term debt, net of unamortiz...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
30,280
33,565
27,658
30,292
Accounts receivable, net
58,134
58,998
59,639
55,659
Other receivables
1,316
322
339
276
Inventories
24,290
16,875
18,882
15,786
Prepaid expenses and other current assets
2,843
2,987
3,574
2,779
Total current assets
116,863
112,747
110,092
104,792
Property and equipment, net
10,697
10,684
10,714
10,854
Operating right of use assets
22,520
22,374
23,265
23,887
Intangible assets, net
10,300
11,015
11,732
12,449
Goodwill
7,230
7,230
7,230
7,230
Other assets
620
606
586
586
Total assets
168,230
164,656
163,619
159,798
Accounts payable
47,650
43,167
35,634
34,933
Current portion of operating lease liabilities
7,404
7,156
7,161
6,953
Accrued expenses and other current liabilities
24,297
20,639
22,785
22,892
Total current liabilities
79,351
70,962
65,580
64,778
Deferred income taxes liability
-
0
0
0
Operating lease liabilities
18,843
19,131
20,195
21,179
Derivative warrant liabilities
96
264
262
112
Conversion option derivative liabilities
7,595
12,591
13,658
7,681
Long-term debt, net of unamortized debt issuance costs
78,611
77,400
76,195
75,023
Other non-current liabilities
19
28
3
10
Total liabilities
184,515
180,376
175,893
168,783
Common stock, 0.0001 par value, authorized 500,000,000 shares 101,707,558 shares issued and 99,973,784 shares outstanding at march31, 2026 and 100,596,918 shares issued and 98,863,144 shares outstanding at december31, 2025
10
10
10
9
Additional paid-in capital
258,635
256,708
252,646
239,432
Treasury stock at cost, 1,733,774 shares at march31, 2026 and december31, 2025
1,019
1,019
1,019
1,019
Accumulated deficit
-273,911
-271,419
-263,911
-247,407
Total stockholders equity (deficit)
-16,285
-15,720
-12,274
-8,985
Total liabilities and stockholders equity (deficit)
168,230
164,656
163,619
159,798
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$58,134K Cash and cashequivalents$30,280K Inventories$24,290K Prepaid expenses andother current assets$2,843K Other receivables$1,316K Total current assets$116,863K Operating right of useassets$22,520K Property and equipment,net$10,697K Intangible assets, net$10,300K Goodwill$7,230K Other assets$620K Total assets$168,230K Accumulated deficit-$273,911K Treasury stock at cost,1,733,774 shares at...$1,019K Total liabilities andstockholders equity...$168,230K Total stockholdersequity (deficit)-$16,285K Additional paid-in capital$258,635K Common stock, 0.0001par value,...$10K Total liabilities$184,515K Total currentliabilities$79,351K Long-term debt, net ofunamortized debt issuance...$78,611K Operating leaseliabilities$18,843K Conversion optionderivative liabilities$7,595K Derivative warrantliabilities$96K Other non-currentliabilities$19K Accounts payable$47,650K Accrued expenses andother current...$24,297K Current portion ofoperating lease...$7,404K

Oncology Institute, Inc. (TOIIW)

Oncology Institute, Inc. (TOIIW)